Abstract:Background: Biological ageing markers are useful to risk stratify morbidity and mortality more precisely than chronological age. In this study, we aimed to develop a novel deep-learning-based biological ageing marker (referred to as RetiPhenoAge hereafter) using retinal images and PhenoAge, a composite biomarker of phenotypic age. Methods: We used retinal photographs from the UK Biobank dataset to train a deep-learning algorithm to predict the composite score of PhenoAge. We used a deep convolutional neural network architecture with multiple layers to develop our deep-learning-based biological ageing marker, as RetiPhenoAge, with the aim of identifying patterns and features in the retina associated with variations of blood biomarkers related to renal, immune, liver functions, inflammation, and energy metabolism, and chronological age. We determined the performance of this biological ageing marker for the prediction of morbidity (cardiovascular disease and cancer events) and mortality (all-cause, cardiovascular disease, and cancer) in three independent cohorts (UK Biobank, the Singapore Epidemiology of Eye Diseases [SEED], and the Age-Related Eye Disease Study [AREDS] from the USA). We also compared the performance of RetiPhenoAge with two other known ageing biomarkers (hand grip strength and adjusted leukocyte telomere length) and one lifestyle factor (physical activity) for risk stratification of mortality and morbidity. We explored the underlying biology of RetiPhenoAge by assessing its associations with different systemic characteristics (eg, diabetes or hypertension) and blood metabolite levels. We also did a genome-wide association study to identify genetic variants associated with RetiPhenoAge, followed by expression quantitative trait loci mapping, a gene-based analysis, and a gene-set analysis. Cox proportional hazards models were used to estimate the hazard ratios (HRs) and corresponding 95% CIs for the associations between RetiPhenoAge and the different morbidity and mortality outcomes. Findings: Retinal photographs for 34 061 UK Biobank participants were used to train the model, and data for 9429 participants from the SEED cohort and for 3986 participants from the AREDS cohort were included in the study. RetiPhenoAge was associated with all-cause mortality (HR 1·92 [95% CI 1·42-2·61]), cardiovascular disease mortality (1·97 [1·02-3·82]), cancer mortality (2·07 [1·29-3·33]), and cardiovascular disease events (1·70 [1·17-2·47]), independent of PhenoAge and other possible confounders. Similar findings were found in the two independent cohorts (HR 1·67 [1·21-2·31] for cardiovascular disease mortality in SEED and 2·07 [1·10-3·92] in AREDS). RetiPhenoAge had stronger associations with mortality and morbidity than did hand grip strength, telomere length, and physical activity. We identified two genetic variants that were significantly associated with RetiPhenoAge (single nucleotide polymorphisms rs3791224 and rs8001273), and were linked to expression quantitative trait locis in various tissues, including the heart, kidneys, and the brain. Interpretation: Our new deep-learning-derived biological ageing marker is a robust predictor of mortality and morbidity outcomes and could be used as a novel non-invasive method to measure ageing. Funding: Singapore National Medical Research Council and Agency for Science, Technology and Research, Singapore.

Development of deep biological ages aware of morbidity and mortality based on unsupervised and semi-supervised deep learning approaches

A Machine Learning-Based Data Mining in Medical Examination Data: a Biological Features-Based Biological Age Prediction Model

A Method for the Early Prediction of Chronic Diseases Based on Short Sequential Medical Data.

Machine Learning-based Biological Ageing Estimation Technologies: A Survey

A Machine Learning Based Aging Measure among Middle-Aged and Older Chinese Adults: the China Health and Retirement Longitudinal Study

Image-based ECG analyzing deep-learning algorithm to predict biological age and mortality risks: interethnic validation

Application of AI in biological age prediction

Deep biomarkers of human aging: Application of deep neural networks to biomarker development.

DeepAge: Harnessing Deep Neural Network for Epigenetic Age Estimation From DNA Methylation Data of human blood samples

Retinal photograph-based deep learning predicts biological age, and stratifies morbidity and mortality risk

Comparison of Machine Learning Techniques for Mortality Prediction in a Prospective Cohort of Older Adults

PsychoAge and SubjAge: development of deep markers of psychological and subjective age using artificial intelligence

Integrating multi-task and cost-sensitive learning for predicting mortality risk of chronic diseases in the elderly using real-world data

Bone Age Assessment Using Artificial Intelligence in Korean Pediatric Population: A Comparison of Deep-Learning Models Trained With Healthy Chronological and Greulich-Pyle Ages as Labels

Application of Machine Learning in Identifying Premature Aging

Application of a deep-learning marker for morbidity and mortality prediction derived from retinal photographs: a cohort development and validation study

Electrocardiogram-Based Heart Age Estimation by a Deep Learning Model Provides More Information on the Incidence of Cardiovascular Disorders

Deep learning model for the prediction of all-cause mortality among long term care people in China: a prospective cohort study

DeepMAge: A Methylation Aging Clock Developed with Deep Learning

Deep learning-based brain age prediction in normal aging and dementia

Deep learning for brain age estimation: A systematic review